Matches in SemOpenAlex for { <https://semopenalex.org/work/W1976139317> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W1976139317 endingPage "50" @default.
- W1976139317 startingPage "43" @default.
- W1976139317 abstract "To investigate the reported differences in catalytic activities of cytochromes P450 (CYP or P450) 3A4 and 3A5, molecular docking studies were conducted of the interactions of 13 compounds with active sites of the reported three-dimensional structure of CYP3A4 and the modeled structure of CYP3A5. The primary sequence of human CYP3A5 was aligned with that of human CYP3A4 (1TQN) using threedimensional modeling software. Docking simulations were carried out after the energy of the CYP3A4 and CYP3A5 structures had been minimized. Kinetic parameters for the substrate oxidations were taken from the literature. Among the substrates that are preferably metabolized by CYP3A4, including carebastine, itraconazole, haloperidol, and fluvastatin, the former three compounds were found to closely dock to the heme region of CYP3A4 but not to that of CYP3A5. The ligand–CYP3A5 interaction energies (U values) for vincristine, R- and S-verapamil, and β-endosulfan were considerably lower than the corresponding ligand–CYP3A4 interaction energies; these substrates also had lower reported Michaelis constants (km) for CYP3A5 than for CYP3A4. Despite higher CYP3A5 km values for α-endosulfan and estradiol, the CYP3A5 U value for estradiol was lower than that for CYP3A4. No marked differences of U values between CYP3A4 and CYP3A5 were observed for midazolam and triazolam, and comparable km values for the oxidations of these two substrates have been reported for CYP3A4 and CYP3A5. Molecular docking simulation could partly explain the differences of the affinities (km) of the substrates for CYP3A4 and CYP3A5 based on the accessibility of substrates to the heme moiety of CYP3A molecules. Biography: Hiroshi Yamazaki has been Professor of Laboratory of Drug Metabolism and Pharmacokinetics in Showa Pharmaceutical University, Tokyo, Japan since 2005. A major area of his interest is polymorphic cytochrome P450 and flavincontaining monooxygenase involved in drug metabolism. He is recognized as a ‘Highly Cited’ researcher in Pharmacology by ISI/Thomson Reuters. Keywords: Accessibility, affinity, CYP3A4, CYP3A5, docking simulation, metabolic activity." @default.
- W1976139317 created "2016-06-24" @default.
- W1976139317 creator A5003947126 @default.
- W1976139317 creator A5037843407 @default.
- W1976139317 creator A5078922881 @default.
- W1976139317 creator A5089044754 @default.
- W1976139317 date "2013-12-29" @default.
- W1976139317 modified "2023-10-17" @default.
- W1976139317 title "Comparison of Catalytic Properties of Cytochromes P450 3A4 and 3A5 by Molecular Docking Simulation" @default.
- W1976139317 doi "https://doi.org/10.2174/1872312807666131229121228" @default.
- W1976139317 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24484539" @default.
- W1976139317 hasPublicationYear "2013" @default.
- W1976139317 type Work @default.
- W1976139317 sameAs 1976139317 @default.
- W1976139317 citedByCount "14" @default.
- W1976139317 countsByYear W19761393172015 @default.
- W1976139317 countsByYear W19761393172016 @default.
- W1976139317 countsByYear W19761393172017 @default.
- W1976139317 countsByYear W19761393172018 @default.
- W1976139317 countsByYear W19761393172019 @default.
- W1976139317 countsByYear W19761393172020 @default.
- W1976139317 countsByYear W19761393172021 @default.
- W1976139317 countsByYear W19761393172022 @default.
- W1976139317 countsByYear W19761393172023 @default.
- W1976139317 crossrefType "journal-article" @default.
- W1976139317 hasAuthorship W1976139317A5003947126 @default.
- W1976139317 hasAuthorship W1976139317A5037843407 @default.
- W1976139317 hasAuthorship W1976139317A5078922881 @default.
- W1976139317 hasAuthorship W1976139317A5089044754 @default.
- W1976139317 hasConcept C109650736 @default.
- W1976139317 hasConcept C159110408 @default.
- W1976139317 hasConcept C181199279 @default.
- W1976139317 hasConcept C185592680 @default.
- W1976139317 hasConcept C2776217839 @default.
- W1976139317 hasConcept C41685203 @default.
- W1976139317 hasConcept C526171541 @default.
- W1976139317 hasConcept C55493867 @default.
- W1976139317 hasConcept C71240020 @default.
- W1976139317 hasConcept C71924100 @default.
- W1976139317 hasConceptScore W1976139317C109650736 @default.
- W1976139317 hasConceptScore W1976139317C159110408 @default.
- W1976139317 hasConceptScore W1976139317C181199279 @default.
- W1976139317 hasConceptScore W1976139317C185592680 @default.
- W1976139317 hasConceptScore W1976139317C2776217839 @default.
- W1976139317 hasConceptScore W1976139317C41685203 @default.
- W1976139317 hasConceptScore W1976139317C526171541 @default.
- W1976139317 hasConceptScore W1976139317C55493867 @default.
- W1976139317 hasConceptScore W1976139317C71240020 @default.
- W1976139317 hasConceptScore W1976139317C71924100 @default.
- W1976139317 hasIssue "1" @default.
- W1976139317 hasLocation W19761393171 @default.
- W1976139317 hasLocation W19761393172 @default.
- W1976139317 hasOpenAccess W1976139317 @default.
- W1976139317 hasPrimaryLocation W19761393171 @default.
- W1976139317 hasRelatedWork W1984464701 @default.
- W1976139317 hasRelatedWork W1988975463 @default.
- W1976139317 hasRelatedWork W2003794789 @default.
- W1976139317 hasRelatedWork W2017184909 @default.
- W1976139317 hasRelatedWork W2031578387 @default.
- W1976139317 hasRelatedWork W2068813982 @default.
- W1976139317 hasRelatedWork W2098807195 @default.
- W1976139317 hasRelatedWork W3002669302 @default.
- W1976139317 hasRelatedWork W4247957203 @default.
- W1976139317 hasRelatedWork W4366831270 @default.
- W1976139317 hasVolume "8" @default.
- W1976139317 isParatext "false" @default.
- W1976139317 isRetracted "false" @default.
- W1976139317 magId "1976139317" @default.
- W1976139317 workType "article" @default.